CytoMed Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions SGD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for CytoMed Therapeutics Limited (GDTC) - Annual data in millions SGD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents4.979.001.582.510.89
Short-Term Investments0.000.000.000.020.04
Cash & Short-Term Investments4.979.001.582.510.93
Accounts Receivable0.120.200.060.010.01
Inventory0.840.680.580.430.24
Other Current Assets0.040.160.050.140.04
Total Current Assets6.0010.102.493.281.47
Non-Current Assets
Property, Plant & Equipment (Net)3.252.062.472.502.30
Long-Term Investments0.220.200.240.270.00
Goodwill0.000.000.000.000.00
Intangible Assets0.090.010.020.030.04
Other Non-Current Assets0.370.000.000.000.00
Total Non-Current Assets4.072.272.732.800.00
Total Assets10.0712.375.236.083.82
Current Liabilities
Accounts Payable0.040.020.010.050.02
Short-Term Debt0.040.033.742.700.04
Current Portion of Long-Term Debt0.040.030.030.040.04
Accrued Liabilities0.360.450.240.140.29
Deferred Revenue0.110.010.010.020.02
Other Current Liabilities0.050.150.160.020.04
Total Current Liabilities0.610.724.172.942.73
Non-Current Liabilities
Long-Term Debt0.390.410.470.540.59
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.420.410.480.550.00
Total Liabilities1.021.124.643.493.34
Stockholders' Equity
Common Stock23.7923.728.916.553.50
Retained Earnings-14.85-12.33-8.20-5.07-3.02
Accumulated Other Comprehensive Income0.02-0.22-0.13-0.03-0.01
Minority Interest0.080.000.000.000.00
Shares Outstanding11.5411.5310.9410.940.00
Total Stockholders' Equity9.0411.250.592.590.48
Total Liabilities & Equity10.0712.375.236.080.00